Immediate Impact
2 from Science/Nature 60 standout
Citing Papers
Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
2024 Standout
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Works of E. Jane Leonard being referenced
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer
2021
Randomized phase 2 study of investigational aurora A kinase (AAK) inhibitor alisertib (MLN8237) + paclitaxel (P) vs placebo + P as second line therapy for small-cell lung cancer (SCLC)
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| E. Jane Leonard | 204 | 154 | 166 | 24 | 410 | |
| Vadim Baykov | 192 | 69 | 160 | 33 | 449 | |
| Anna Llort | 139 | 37 | 156 | 19 | 437 | |
| Jeffrey Knipstein | 98 | 50 | 326 | 15 | 439 | |
| Gina M. Ney | 81 | 73 | 266 | 19 | 424 | |
| Sameer A. Greenall | 139 | 31 | 201 | 21 | 418 | |
| Cline Mj | 174 | 24 | 162 | 24 | 409 | |
| Danielle Shafer | 148 | 17 | 168 | 30 | 388 | |
| Τατιάνα Τζένου | 120 | 20 | 173 | 25 | 382 | |
| Mecide Gharibo | 193 | 17 | 169 | 33 | 386 | |
| Tharu M. Fernando | 205 | 24 | 236 | 18 | 421 |
All Works
Login with ORCID to disown or claim papers
Loading papers...